NatWest Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-102,261
| Closed | -$10.3M | – | 220 |
|
|
2015
Q3 | $10.3M | Sell |
102,261
-20,358
| -17% | -$2.06M | 0.23% | 52 |
|
|
2015
Q2 | $15.1M | Buy |
122,619
+16,542
| +16% | +$2.03M | 0.19% | 32 |
|
|
2015
Q1 | $12.1M | Sell |
106,077
-17,874
| -14% | -$2.05M | 0.16% | 46 |
|
|
2014
Q4 | $12.5K | Sell |
123,951
-12,996
| -9% | -$1.31K | 0.11% | 44 |
|
|
2014
Q3 | $12.5K | Buy |
136,947
+25,047
| +22% | +$2.29K | 0.11% | 50 |
|
|
2014
Q2 | $9.59M | Sell |
111,900
-70,173
| -39% | -$6.01M | 0.4% | 73 |
|
|
2014
Q1 | $14.3M | Sell |
182,073
-6,057
| -3% | -$477K | 0.64% | 41 |
|
|
2013
Q4 | $14.2M | Buy |
188,130
+5,622
| +3% | +$426K | 0.36% | 66 |
|
|
2013
Q3 | $12.8M | Buy |
182,508
+3,702
| +2% | +$259K | 0.37% | 61 |
|
|
2013
Q2 | $10.4M | Buy |
+178,806
| New | +$10.4M | 0.15% | 113 |
|